AdvanCell
Manufacturing · Australia · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Macquarie House 167 Macquarie St L 7, Sy...Website
www.advancell.com.auRevenue
$10.6 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About AdvanCell
AdvanCell is a clinical stage radiopharmaceutical company that specializes in developing novel targeted alpha therapies aimed at improving survival and quality of life for cancer patients. The company has a diverse portfolio targeting various cancers, including prostate, breast, and lung cancer. AdvanCell utilizes proprietary production technology to ensure a reliable supply of alpha isotopes for its therapies. The company seeks partnerships to further develop its targeted alpha therapy initiatives.Explore more
AdvanCell Org Chart
Get the full picture
Sign in to uncover key details.
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is AdvanCell your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on AdvanCell recently announced quarterly report
Check if AdvanCell has recently received funding, and reach out quickly before it becomes old news!
Click to see if AdvanCell had a recent Job posting/layoffs
Funding: Get notified immidiatlly once AdvanCell has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
AdvanCell, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at AdvanCell
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when AdvanCell launches new products
Check out if AdvanCell is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined AdvanCell as Masked Content
Find more new buyers
Compare Similar Companies to AdvanCell
Compare insights from companies similar to AdvanCell, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
AdvanCell is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
AdvanCell is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about AdvanCell.
AdvanCell financials insights
Gather financial insights about AdvanCell, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Series B
$18M
2025
Series C
$112M
Other Financing Round
$18M
AdvanCell Tech Stack
A closer look at the technologies used by AdvanCell
See more technologies
Most Recent Scoops
Facilities Relocation / Expansion
Facilities Relocation/Expansion, Leasing, Manufacturing Operations
Lateral Move
Executive Move
Executive Moves, Lateral Move
New Hire
Executive Move
Executive Moves, New Hire
New Hire
Executive Move
Executive Moves, New Hire
Lateral Move
Executive Move
Executive Moves, Lateral Move
AdvanCell News & Media
AdvanCell Signs 128,000 Square Foot, Full Building Lease at IQHQ's Innovation Park in Andover, Massachusetts
Newly Constructed Phase 2 now 100% Leased Further Solidifies Innovation Park as Boston's Premier Advanced Manufacturing Destination BOSTON, June 22, 2026 /PRNewswire/ -- IQHQ, Inc. today announced that AdvanCell has signed a long-term ~128,000 square foot lease for the entire 1 Corporate...AdvanCell Names New CTO and CSO, Expanding Executive Leadership Team
AdvanCell named Justyna Kelly as its new Chief Technology Officer (CTO) and François Gaudet as Chief Scientific Officer (CSO).AdvanCell and 48Hour Discovery Enter Exclusive Agreement to Advance a Lead-212 Radioligand Therapy Program
AdvanCell and 48Hour Discovery Announce Collaboration and Exclusive Licensing Agreement to Develop a Lead-212 Alpha Radioligand Therapy Program EDMONTON, ALBERTA, CANADA, February 2, 2026 /EINPresswire.com/ -- AdvanCell, a clinical-stage …AdvanCell Appoints Philina Lee, PhD as Chief Executive Officer to Lead US Expansion and ...
SYDNEY & BOSTON, November 17, 2025--AdvanCell Pty Ltd ("AdvanCell"), a clinical-stage radiopharmaceutical company developing innovative targeted alpha therapies for cancer, today announced the appointment of Philina Lee, PhD as Chief Executive Officer and member of the Board of Directors. Dr Lee will head AdvanCell’s US expansion, accelerating clinical, manufacturing, and partnership activities to advance lead clinical candidate 212Pb-ADVC001 and the company’s innovative radiopharmaceutical port
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding AdvanCell
Sign Up For FreeTo access detailed company insights
AdvanCell is a clinical stage radiopharmaceutical company that specializes in developing novel targeted alpha therapies aimed at improving survival and quality of life for cancer patients. The company has a diverse portfolio targeting various cancers, including prostate, breast, and lung cancer. AdvanCell utilizes proprietary production technology... Read More
